Publications by authors named "Charles Turck"

Claim this Profile
D
Development of a Medication-Use Evaluation Template for Andexanet Alfa in the Reversal of Anticoagulation With Factor Xa Inhibitors.
Toni Fera, Allison Burnett, Jessica Grandoni, Mary R Moore, Barbara B Nussbaum, Charles J Turck

J Pharm Pract· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
When to Pick the Nose: Out-of-Hospital and Emergency Department Intranasal Administration of Medications.
Megan A Rech, Brian Barbas, Whitney Chaney, Elizabeth Greenhalgh, Charles Turck

Ann Emerg Med· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Major publications in the critical care pharmacotherapy literature: January-December 2014.
Sarah A Day, Michaelia Cucci, Molly E Droege, Jenna M Holzhausen, Bridgette Kram, Charles J Turck

Am J Health Syst Pharm· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Major publications in the critical care pharmacotherapy literature: January-December 2013.
Megan A Rech, Sarah A Day, Jenna M Kast, Elisabeth E Donahey, Mehrnaz Pajoumand, Charles J Turck

Am J Health Syst Pharm· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Major publications in the critical care pharmacotherapy literature: February 2012 through February 2013.
Charles J Turck, Erin Frazee, Bridgette Kram, Mitchell J Daley, Sarah A Day

Am J Health Syst Pharm· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current and emerging strategies for treating hepatic encephalopathy.
Keith J Foster, Sonia Lin, Charles J Turck

Crit Care Nurs Clin North Am· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of albuterol 1.25 mg and 0.62 mg for nebulization in 6- to 12-year-old children with moderately severe asthma.
James Kemp, Charles J Turck, John M York

Adv Ther· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacoeconomics of Surgical Interventions vs. Cyclooxygenase Inhibitors for the Treatment of Patent Ductus Arteriosus.
Charles J Turck, Wallace Marsh, James G Stevenson, John M York, Henry Miller

J Pediatr Pharmacol Ther· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An open label comparison of calfactant and poractant alfa administration traits and impact on neonatal intensive care unit resources.
Jeffrey S Gerdes, William Seiberlich, Emidio M Sivieri, Wallace Marsh, Dwight L Varner, Charles J Turck

J Pediatr Pharmacol Ther· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacist interventions in an anticoagulation clinic.
Katherine Anne Campbell, Charles J Turck, Jill S Burkiewicz, Laura R Peppers

Am J Health Syst Pharm· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis